Stay updated on Efficacy of EID Natalizumab in RRMS Clinical Trial
Sign up to get notified when there's something new on the Efficacy of EID Natalizumab in RRMS Clinical Trial page.

Latest updates to the Efficacy of EID Natalizumab in RRMS Clinical Trial page
- Check4 days agoChange DetectedThe page now includes a recruitment status update indicating no participant enrollment, adds user-focused sections (How to Read a Study Record, Common Questions, How to Join a Study), and standardizes the Intervention/Treatment label while updating the revision to v3.6.0 (removing the previous v3.5.5).SummaryDifference0.2%

- Check12 days agoChange DetectedThe page revision was updated to v3.5.5, replacing the previous v3.5.4 revision. This indicates a minor update to the document on the ClinicalTrials.gov page.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe page revision label changed from v3.5.3 to v3.5.4, indicating an updated version of the page. This reflects maintenance or minor updates without altering the study details or user-facing information.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page footer revision number was updated from v3.5.2 to v3.5.3, indicating a minor platform/version update without changing the displayed study details.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision tag updated from v3.5.0 to v3.5.2. This appears to be a minor technical update with no visible changes to content or functionality on the page.SummaryDifference0.0%

- Check84 days agoChange DetectedThe location entry changed from Napoli, Italy, 80131 to Naples, Italy, 80131; the postal code remains the same.SummaryDifference0.0%

Stay in the know with updates to Efficacy of EID Natalizumab in RRMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of EID Natalizumab in RRMS Clinical Trial page.